Surrozen Inc. share price logo

Surrozen Inc.

NASDAQ: SRZN

Small Cap

$21.64

-0.31

(-1.41%)

as on

Surrozen Inc. Stock Performance

as on August 7, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $21.29
    $22.40
    downward going graph

    1.62%

    Downside

    3.51%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.03
    $35.00
    downward going graph

    58.27%

    Downside

    61.74%

    Upside

    downward going graph

Surrozen Inc. share price movements today

Previous Close
$21.95
Open
$21.36
Volume
266.2K
Day's Low - High
$21.29 - $22.40
52 Week Low - High
$9.03 - $35.00

Surrozen Inc. Historical Returns

1 Month Return
-5.95 %
3 Month Return
-29.63 %
1 Year Return
+ 139.65 %
3 Year Return
+ 70.73 %
5 Year Return
0 %

Surrozen Inc. Stock Fundamentals & Key Indicators

Check Surrozen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$254.8M

EPS (TTM)

-3.7

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-42.7M

Revenue (TTM)

7.5M

Profit Margin

0.00%

Return On Equity TTM

-62.80%

Surrozen Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Surrozen Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Surrozen Inc. image
Surrozen Inc.
BUY$254.8MNANA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$41.9B606.97%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$122.9B141.21%27.8535.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$79.1B26.4%18.8327.87%0.48%

Stock Returns calculator for Surrozen Inc. Stock including INR - Dollar returns

The Surrozen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Surrozen Inc. investment value today

Current value as on today

₹2,60,066

Returns

₹1,60,066

(+160.07%)

Returns from Surrozen Inc. Stock

₹1,39,646 (+139.65%)

Dollar Impact

₹20,420 (+20.42%)

Analyst Recommendation on Surrozen Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Surrozen Inc.. Average target price of $42.5

Surrozen Inc. Share Price Target

Get share price movements and forecasts by analysts on Surrozen Inc..

What analysts predicted

49.08%UPSIDE

Target Price

$42.5

Current Price

$21.64

Analyzed by

8 Analysts

Target

$42.50

Surrozen Inc. target price $42.5, a slight upside of 49.08% compared to current price of $21.64. According to 8 analysts rating.

Indian Investors' Interest in Surrozen Inc. Stock

Search interest for Surrozen Inc. Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Surrozen Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
4
-
10
0
0
0
0
0
5
Gross Profit
-
0
0
10
0
0
0
0
0
4
Operating Income
-9
-9
-9
1
-8
-9
-9
-10
-12
-10
EBITDA
-
-8
-24
-1
-27
-26
39
-71
-183
-127
Interest Expense
-
0
-
-
1
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-8
-8
-25
-1
-28
-26
39
-71
-183
-127
Income Tax Expense
-
0
-
-
0
-
-
-
-
-
Net Income
-8
-8
-25
-1
-28
-26
39
-71
-183
-127
Net Profit Margin
0.00%
-212.98%
0.00%
-14.34%
-4280.76%
-2743.64%
4043.34%
-7288.20%
-34689.20%
-2550.10%

Surrozen Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
12
12
10
3
Gross Profit
-2
-3
12
-27
10
2
Operating Income
-32
-54
-44
-45
-25
-42
EBITDA
-31
-52
-42
-41
-62
-241
Interest Expense
0
2
1
-
-
-
Depreciation
1
2
1
1
1
0
Income Before Tax
-32
-54
-36
-43
-63
-242
Income Tax Expense
0
-2
-8
2
-63
-
Net Income
-32
-52
-27
-43
-63
-242
Net Profit Margin
0.00%
0.00%
-221.35%
-344.34%
-596.56%
-6960.77%

Surrozen Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-8
-25
-1
-28
-26
39
-71
-183
-127
Operating Cash Flow
-8
-5
-6
3
-9
-6
-9
-5
-12
Investing Cash Flow
0
-
-
0
0
0
0
0
0
Financing Cash Flow
0
16
0
0
76
-5
0
13
30
Change in Cash
-8
10
-6
3
67
-11
-9
7
17

Surrozen Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-32
-54
-36
-43
-63
-242
Operating Cash Flow
-29
-48
-44
-40
-17
-30
Investing Cash Flow
-15
-77
38
51
0
0
Financing Cash Flow
50
124
-2
0
16
85
Change in Cash
5
-1
-8
11
-1
54

Global Institutional Holdings in Surrozen Inc.

Funds
Holdings
Spruce Street Capital LP
3.72%
Schonfeld Strategic Advisors LLC
0.87%
Vivo Capital, LLC
2.24%
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
0.64%
Empery Asset Management, LP
0.91%
See all

Insights on Surrozen Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, SRZN stock has moved up by 139.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 326.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 567.4% return, outperforming this stock by 496.7%

About Surrozen Inc.

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.
OrganisationSurrozen Inc.
Headquarters171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEOMr. Craig C. Parker M.B.A.
E-voting on sharesClick here to vote

Key Management of Surrozen Inc.

Name

Title

Dr. Roeland Nusse Ph.D.

Co-Founder & Member of Scientific Advisory Board

Dr. Calvin Kuo M.D., Ph.D.

Co-Founder & Member of Scientific Advisor

Dr. K. Christopher Garcia Ph.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Charles Williams

COO & Corporate Secretary

Dr. Yang Li Ph.D.

Executive Vice President of Research

Mr. Andrew Maleki

Chief Financial Officer

Dr. Daniel L. Chao M.D., Ph.D.

VP & Head of Clinical Development

Mr. Michael Lauw M.S.W.

Senior Vice President of Development Operations

Esther Jhun

Controller

Mr. Craig C. Parker M.B.A.

CEO, President & Director

FAQs

What is Surrozen Inc. share price today?

Surrozen Inc. share price today is $21.64 as on at the close of the market. Surrozen Inc. share today touched a day high of $22.40 and a low of $21.29.

What is the 52 week high and 52 week low for Surrozen Inc. share?

Surrozen Inc. share touched a 52 week high of $35.00 on and a 52 week low of $9.03 on . Surrozen Inc. stock price today i.e. is closed at $21.64,which is 38.17% down from its 52 week high and 139.65% up from its 52 week low.

What is Surrozen Inc.'s market capitalisation today?

Surrozen Inc. market capitalisation is $0.00T as on .

How to invest in Surrozen Inc. Stock (SRZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Surrozen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Surrozen Inc. Shares that will get you 0.0693 shares as per Surrozen Inc. share price of $21.64 per share as on August 7, 2026 at 8:45 am IST.

What is the minimum amount required to buy Surrozen Inc. Stock (SRZN) from India?

Indian investors can start investing in Surrozen Inc. (SRZN) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Surrozen Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Surrozen Inc. share’s latest price of $21.64 as on August 7, 2026 at 8:45 am IST, you will get 0.4621 shares of Surrozen Inc.. Learn more about fractional shares .